GlassScriptPhysician profile
Joseph A Scian
NPI 1093776551
$754.78
in general payments reported to CMS, 2019-2025
17 companies · $138 in 2025
The $138 reported for 2025 was less than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $290 · 2020: $27.32 · 2021: $154 · 2022: $14.21 · 2023: $114 · 2024: $16.72 · 2025: $138.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $269.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $269.02 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $245.00 | 2019-2021 | |
| Exact Sciences Corporation | $97.41 | 2023-2025 | Cologuard Collection Kit |
| Astellas Pharma US INC | $72.10 | 2023-2025 | Veozah |
| Pfizer INC. | $45.97 | 2019-2021 | |
| Exeltis, USA INC. | $41.00 | 2019-2022 | |
| Alydia Health | $40.22 | 2021 | |
| Bayer Healthcare Pharmaceuticals INC. | $38.57 | 2020-2021 | |
| Hologic Sales and Service, LLC | $37.86 | 2019 | |
| Sumitomo Pharma America, INC. | $24.82 | 2025 | Myfembree |
| Avion Pharmaceuticals | $24.18 | 2019-2021 | |
| Optumhealth Care Solutions, LLC | $16.65 | 2025 | Vivify Health Care Team Portal 001, Eitan Medical |
| Millicent US INC | $16.20 | 2023 | Intrarosa, Femring |
| Mycovia Pharmaceuticals, INC. | $15.10 | 2023 | Vivjoa |
| Pacira Pharmaceuticals Incorporated | $14.60 | 2023 | Exparel |
| Dysis Medical, INC. | $12.96 | 2021 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Meditrina | $12.14 | 2023 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
Research and ownership
$5.00 in ownership or investment interests, as reported to CMS. These are holdings a clinician or an immediate family member has in a company, not payments received.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Joseph Scian listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.